Hyperglycemia and the consequent accelerated nonoverexpression of TGF-␤1.
gest that increased glycated albumin helps promote the shown to bind to well-characterized sites in serum albumin and render susceptible ε-amino groups inaccessible glomerular overexpression of TGF-␤ that is observed in diabetes [21] [22] [23] , direct evidence supporting this relafor condensation with free reducing sugar, but lacks the 2,6 dichloro substitution required for inhibition of cyclotionship in vivo is lacking. To examine this hypothesis, we assessed glomerular TGF-␤1 expression in db/db mice oxygenase (COX) [24] [25] [26] . We confirmed low COX inhibitory activity by incubating COX-1 purified from ram after treatment with a compound that impedes the condensation of glucose with albumin. We report that reseminal vesicles in the presence of cofactors, substrate, and 0 to 1000 mol/L of compound, and measuring the ducing the burden of glycated albumin by inhibiting its formation, even in the presence of hyperglycemia, sigperoxidase activity according to the vendor's instructions (Cayman Chem Co., Ann Arbor, MI, USA). The IC 50 nificantly decreases glomerular TGF-␤1 expression and associated pathobiologic abnormalities. To our knowlfor COX inhibition of 23CPPA was Ͼ600 mol/L, compared to an IC 50 of 1 mol/L for diclofenac assayed by edge, this is the first in vivo study demonstrating a causal link between glycated albumin and TGF-␤1-stimulated the same procedure. The ability of the compound to inhibit the nonenzymatic glycation of albumin in vitro glomerulosclerosis.
was tested by incubating 0 to 1000 mol/L of 23CPPA with serum albumin for two days at room temperature METHODS in the presence of 50 mmol/L glucose in buffered saline,
Experimental animals
and determining the amount of glycated albumin formed. This was accomplished by processing the reaction mixThe studies were performed in male diabetic db/db mice and age-matched male nondiabetic db/m mice (Jacktures through Amicon filters to remove free glucose and compound, followed by application to phenylboronate son Laboratory, Bar Harbor, ME, USA) that were provided food and water ad libitum. At baseline, midpoint agarose (PBA) to separate nonglycated (unbound) from glycated (bound) albumin. The albumin concentration and completion of the experimental protocol, blood was obtained from the retro-orbital sinus for measurement in the bound fraction, eluted with 0.1 mol/L sorbitol, was measured by immunoassay with anti-human albumin of glucose and glycated albumin and 24-hour urines were collected for measurement of albumin excretion. specific antibody [27] . The IC 50 for inhibition of albumin glycation by test compound in this assay was 1 mol/L.
Treatment protocol
Analytical and immunoassay procedures Diabetic mice were divided into two groups of six, one of which received test compound and the other serving Glucose was determined by the glucose oxidase method (Sigma, St. Louis, MO, USA). Urine albumin was meaas the diabetic control. Compound was administered by gavage for eight consecutive weeks at a dose of 10 mg/kg sured with a competitive enzyme-linked assay that has been described previously [19] . Serum concentrations of body wt/day, commencing when animals were 8 weeks old. Control diabetic and nondiabetic mice received daily glycated albumin were measured after affinity chromatography on PBA as described above, with determinasaline gavage for the same 8-week period. At the conclusion of the treatment period, one kidney from each anition of the albumin concentration in the 0.1 mol/L sorbitol elution by immunoassay specific for mouse albumin. mal was harvested for RNA extraction from renal cortex (separated by gross dissection), with a portion of the RNA hybridization analysis snap frozen specimen reserved for in situ hybridization studies. The other kidney was fixed by immersion in 10%
Northern analysis. RNA extracted from snap-frozen renal cortex was prepared as previously described [9, neutral buffered formalin and embedded in paraffin for histologic examination.
10, 19]. Total RNA (20 g from each animal) was electrophoPreparation and analysis of test compound resed on 1.2% agarose gels, transferred onto nylon membranes, and ultraviolet wave cross-linked. Integrity and The compound (23CPPA) was synthesized via condensation of 2-bromophenylacetic acid with a chloro-substiequal loading of the samples were assessed by methylene blue staining of the transferred RNA. The membranes tuted aniline and purified through filtration, organic extraction and crystallization by described techniques [24] .
were hybridized with 32 P-labeled cDNA probes encoding fibronectin and ␣1(IV) collagen as described [9, 10, 19] . It migrated as a single spot on silica gel thin layer chromatography, exhibited appropriate aromatic and acid proAfter hybridization, blots were washed for ten minutes in 2 ϫ standard sodium citrate (SSC) at room temperature, tons on nuclear magnetic resonance (NMR), and had the correct composition on elemental analysis (C 14 H 12 ClNO 2 ), then for five minutes in 2 ϫ SSC/1% sodium dodecyl sulfate (SDS) at 62ЊC, then for five minutes in 0.1 ϫ with a molecular weight of 261.7 and a melting point of 102ЊC. This compound is in the same structural class as SSC/0.1% SDS at 62ЊC. The membranes were autoradiographed with intensifying screens at Ϫ70ЊC for up to ten the anti-inflammatory agent diclofenac, which has been The db/db diabetic mutant mouse develops hyperglyber. After hybridization, sections were washed once cemia associated with obesity and insulin resistance a few in 2 ϫ SSC at room temperature for 30 minutes, once weeks after birth, and exhibits pronounced glomerular in 2 ϫ SSC at 65ЊC, and once in 0.1 ϫ SSC at 65ЊC. mesangial expansion by age 16 weeks [18, 19, [33] [34] [35] . Slides were equilibrated with buffer I (100 mmol/L Tris General characteristics of the experimental animals used HCl/150 mmol/L NaCl, pH 7.5) for five minutes. Antiin the present study conformed with those known to be digoxigenin antibody conjugated to alkaline phosphatase associated with this model (Table 1 ). The diabetic db/db (1:5000) was applied to the slides and incubated in a mice were obese and hyperglycemic at the start and conhumid chamber for two hours at room temperature.
clusion of the study. The mean body weight was greater After two 15-minute washes in buffer I, the sections were in db/db mice compared to db/m controls throughout the equilibrated with developing buffer (100 mmol/L Tris/ experimental period, although diabetic animals stopped 100 mmol/L NaCl/50 mmol/L MgCl 2 , pH 9.5) for five gaining weight between ages 12 and 16 weeks, consistent minutes. The color reaction was developed by NBT/ with entry into an insulin-deficient catabolic state as re-BCIP (Boehringer) according to the manufacturer's inported in this rodent model [34, 35] . The treatment prostructions. Quantitation was performed by computer tocol did not affect body weight or blood glucose; since program IMAGE-PRO PLUS (Media Cybernetics, Silthe test compound binds to albumin and does not react ver Spring, MD, USA).
with free glucose, no effect on metabolic status was exGlomerular pathology pected. The protocol was well tolerated by the mice and had no obvious toxicity. Necropsy revealed no gross Random sections (3 m thick) of the renal cortex were pathology in major organs in the treated mice. Kidney stained with periodic acid-Schiff (PAS). Sections were weights at the end of the study were significantly greater coded and read by an observer unaware of the experiin diabetic compared to nondiabetic controls, and the mental group from which they were derived. Ten glomermean kidney weight was significantly less in the db/db uli in the outer cortex were selected at random from each mice that received test compound than in the db/db animal in each experimental group. Mesangial matrix controls. fraction was determined as PAS positive material present in the mesangial region, exercising care to exclude celluGlycated albumin lar elements. The mesangial matrix area was calculated Serum concentrations of glycated albumin in diabetic as the fraction of total glomerular tuft cross-sectional animals were Ϸ40% higher than in nondiabetic mice at area as previously described [19] . Values obtained with this method were consistent with those reported by other the start of the experimental period, reflecting exposure 
Albumin excretion
Increased albumin excretion, the established parameter of early diabetic renal dysfunction [36, 37] , was presto a hyperglycemic milieu during the preceding one to ent in the db/db mice by age eight weeks, and albumin two weeks [2] [3] [4] . Glycated albumin concentrations in excretion remained significantly elevated in db/db condiabetic mice receiving test compound were significantly trols compared to db/m mice at levels consistent with lower than in the corresponding diabetic controls at the those reported by other investigators using similar methmidpoint and conclusion of the study (Table 2 ). This susodology (Fig. 4 ) [38] . The db/db mice receiving test comtained reduction in glycated albumin occurred despite the pound showed a 45% reduction in albumin excretion persistent and marked elevation in blood glucose concen- (Fig. 4) . The absence of a significant difference in the trations in the db/db mice treated with test compound. mean body weight in treated versus control diabetic mice supports the interpretation that the decrease in albumin Glomerular TGF-␤1 expression excretion was not due to caloric deprivation, although In situ hybridization studies demonstrated that glothe lack of complete normalization of albumin excretion merular TGF-␤1 expression was markedly increased in is consistent with the continued severe hyperglycemia. db/db mice, consistent with previous observations [21] . Compared to nondiabetic mice, diabetic control mice DISCUSSION showed a four-to fivefold selective increase in TGF-␤1
The results of these studies provide evidence that glomRNA in a mesangiocapillary pattern within the glomermerular overexpression of TGF-␤1 in diabetes derives ular tuft (Fig. 1 A-D) . This increase was reduced by 45% at least in part from the elevated circulating glycated in diabetic animals that received test compound (Fig. 1E) albumin concentrations associated with this disease. Glyin which the treatment protocol significantly decreased cated albumin is known to activate the TGF-␤ system glycated albumin but not glucose concentrations.
in glomerular mesangial and endothelial cells [9, 12] , and Matrix expression and glomerular morphometry treatment with anti-TGF-␤ antibody has been shown to prevent pathology in the db/db mouse [21], suggesting Northern blot analysis indicated that corresponding changes in renal ECM protein expression accompanied that TGF-␤ may be the common downstream mediator of deleterious factors promoting glomerular fibrosis in the changes in TGF-␤1 expression. Steady state levels of mRNAs encoding fibronectin and ␣1 (IV) collagen diabetes. The increased glomerular TGF-␤1 mRNA in diabetic mice was significantly reduced in conjunction were significantly greater in the renal cortex from db/db controls compared to nondiabetic db/m mice, as prewith a lowering of serum glycated albumin concentrations by test compound, consistent with the interpretaviously reported (Fig. 2) [19, 21] . Densitometric scanning of the exposed autoradiographs and calculation of tion that the associated amelioration of matrix protein overexpression and glomerulosclerosis were mediated ECM protein mRNA levels in relation to the mrpL32 standard indicated that renal expression of fibronectin by this reduction in glomerular TGF-␤1. The treatment protocol also decreased urine albumin was normalized, and expression of ␣1 (IV) collagen was significantly reduced, in db/db mice treated with test excretion in db/db mice, a finding of interest in view of the report implicating increased glycated albumin to compound (Fig. 2) .
The increased renal ECM and TGF-␤1 expression in perm-selective changes in the glomerular basement membrane that underlie albuminuria early in the course db/db controls at the conclusion of the study was accompanied by the glomerular histopathologic changes that of diabetes [39] . The lowering of urinary albumin in association with normalization of serum glycated albuhave been described in this model, including diffuse Fig. 1 . In situ hybridization with antisense transforming growth factor-␤1 (TGF-␤1) riboprobe at age 16 weeks in db/m (A), db/db (B), and db/db mice after 8 weeks of treatment with test compound (C ). Sense TGF-␤1 riboprobe in 16-week-old salinetreated db/db mouse showed absence of hybridization signal as negative control (D). Quantitation (E ) was performed as described in the text in each of 4 to 6 animals in each experimental group, and calculated as area of signal ( 2 ) divided by area of glomerulus ( 2 ). *P Ͻ 0.05 vs. db/m control; #P Ͻ 0.05 vs. db/db control.
Fig. 2. Renal fibronectin (A) and ␣1 (IV) collagen (B) gene expression in experimental animals.
Total RNA was extracted from snapfrozen renal cortex when animals were killed at the end of the study period. Fibronectin and ␣1 (IV) collagen mRNA levels were calculated in relation to mrpL32 after densitometric scanning of the exposed films. Results represent mean Ϯ SEM of 4 to 6 animals in each group when the ratio of fibronectin or collagen IV mRNA to mrpL32 RNA in db/m saline-treated mice is assigned an arbitrary value of 1. *P Յ 0.05 in db/db control () vs. db/m (ᮀ); #P Յ 0.05 in db/db treated with test compound ( ) vs. corresponding db/db control. treatment did not affect albuminuria in db/db mice [21], prompting the interpretation that TGF-␤ is not a key factor in the glomerular hemodynamic and permeability changes responsible for proteinuria and/or that proteinuria promotes progression of renal disease through activation of the tubulointerstitial TGF-␤ system [40, 41] . Whereas our finding that the test compound lowered, but did not normalize, urinary albumin does not negate this interpretation, it does suggest that decreasing glycated albumin may ameliorate proteinuria by TGF-␤1-independent mechanisms. Further, the decreased urinary albumin cannot be ascribed to inhibition of COX activity, which can modulate pathological renal hemodynamics contributory to diabetic nephropathy [42] , since the test compound has very low affinity for COX enzymes (IC 50 Ϸ600 mol/L compared to 1 mol/L for diclofenac). compound, which normalized serum glycated albumin, arrested structural, functional and cell biology abnormalities associated with diabetic nephropathy even though the animals remained markedly hyperglycemic. Thus, min lends credence to this hypothesis. It is not clear if inhibiting the formation of glycated albumin protected a lessening of the stimulation of TGF-␤1 by glycated against the nephropathogenic effects of this glycated proalbumin contributed to this reduction in albumin excretion. A recent study found that anti-TGF-␤ antibody tein independent of anti-hyperglycemic therapy. It is un- cult to achieve and may be associated with hypoglycemic 
